NCT06826040View on ClinicalTrials.gov

SKB445 for Injection in Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

February 5, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Advanced Solid Tumors
Interventions
DRUG

SKB445 for injection

SKB445 for injection is administered every 3 weeks (q3w) until radiographic disease progression (PD), intolerable toxicity, death, or discontinuation of treatment, whichever occurs first.

Trial Locations (1)

250117

RECRUITING

Cancer Hospital of Shandong First Medical University, Jinan

All Listed Sponsors
lead

Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

INDUSTRY